Nostos Genomics
Company Overview
Nostos Genomics is focused on helping people with genetic diseases by leveraging artificial intelligence in genomics to provide fast and accurate diagnosis.
Mission and Vision
About 475 million people worldwide suffer from rare diseases, with over 80% being genetic in nature. The average diagnosis time is seven years, which is a significant burden for patients and families. Nostos Genomics aims to improve the accuracy, speed, and accessibility of genetic testing, empowering patients to make informed health decisions.
They address the bottleneck in genomics which is the interpretation of genetic variants and identification of disease-causing mutations, using their AI-driven variant interpretation platform called AION. AION automatically identifies likely pathogenic variants in less than 2 minutes, significantly improving the diagnostic yield.
Team
The company has an interdisciplinary team including experts in software, data science, genetics, and healthcare. Key team members include co-founders, scientists, engineers, and product managers.
Technology and Products
The AI-driven platform AION helps genetic testing labs scale their operations by automating variant interpretation with fast, accurate, and reliable decision-support. It provides comprehensive reports and results exports automatically, with a white-box approach to ensure human expert verification.
Compliance and Certifications
Nostos Genomics is GDPR compliant and the AION platform is CE-IVDR certified, ensuring high standards of data protection and medical device regulation compliance.